rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-3-10
|
pubmed:abstractText |
The objective of this study is to determine the impact of human leukocyte antigen (HLA)-B*51-restricted cytotoxic T-lymphocyte (CTL) pressure on the development of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1473-5571
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
13
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
F15-22
|
pubmed:meshHeading |
pubmed-meshheading:20160632-Drug Resistance, Viral,
pubmed-meshheading:20160632-HIV Infections,
pubmed-meshheading:20160632-HIV-1,
pubmed-meshheading:20160632-HLA-B Antigens,
pubmed-meshheading:20160632-Humans,
pubmed-meshheading:20160632-Immune Evasion,
pubmed-meshheading:20160632-Immunodominant Epitopes,
pubmed-meshheading:20160632-Molecular Sequence Data,
pubmed-meshheading:20160632-Mutation,
pubmed-meshheading:20160632-Reverse Transcriptase Inhibitors,
pubmed-meshheading:20160632-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:20160632-Viral Load
|
pubmed:year |
2010
|
pubmed:articleTitle |
Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.
|
pubmed:affiliation |
AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan. higatana@imcj.acc.go.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|